Ocean Biomedical, Inc. (OCEA)
NASDAQ: OCEA · Real-Time Price · USD
0.457
-0.023 (-4.88%)
Jan 22, 2025, 11:58 AM EST - Market open

Ocean Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-26.62-114.47-17.36-62.34-1.65-0.23
Other Amortization
-0.63----
Loss (Gain) on Equity Investments
4.010.71----
Stock-Based Compensation
0.841.8712.3856.55--
Other Operating Activities
18.9100.651.18---
Change in Accounts Payable
0.741.232.81---
Change in Other Net Operating Assets
-0.39-0.05-4.741.590.23
Operating Cash Flow
-2.53-9.43-0.99-1.05-0.06-
Short-Term Debt Issued
-8.260.74---
Long-Term Debt Issued
-0.65----
Total Debt Issued
1.648.910.74---
Short-Term Debt Repaid
--2.1----
Total Debt Repaid
--2.1----
Net Debt Issued (Repaid)
1.646.810.74---
Issuance of Common Stock
-14.26-1.02--
Other Financing Activities
0.1-10.670.230.10.06-
Financing Cash Flow
1.7410.40.971.110.06-
Net Cash Flow
-0.790.97-0.030.06--
Free Cash Flow
-2.53-9.43-0.99-1.05-0.06-
Free Cash Flow Per Share
-0.09-0.36-0.04-0.06-0.00-
Levered Free Cash Flow
1.24-0.444.6122.33--
Unlevered Free Cash Flow
2.560.035.3922.33--
Change in Net Working Capital
-3.26-5.21-3.09-4.74--
Source: S&P Capital IQ. Standard template. Financial Sources.